168 related articles for article (PubMed ID: 8270269)
21. Protective effects of a live attenuated bovine leukaemia virus vaccine with deletion in the R3 and G4 genes.
Reichert M; Cantor GH; Willems L; Kettmann R
J Gen Virol; 2000 Apr; 81(Pt 4):965-9. PubMed ID: 10725422
[TBL] [Abstract][Full Text] [Related]
22. Ovine MHC class II DRB1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma.
Nagaoka Y; Kabeya H; Onuma M; Kasai N; Okada K; Aida Y
Cancer Res; 1999 Feb; 59(4):975-81. PubMed ID: 10029093
[TBL] [Abstract][Full Text] [Related]
23. Antibody response against three widespread bovine viruses is not impaired in Holstein cattle carrying bovine leukocyte antigen DRB3.2 alleles associated with bovine leukemia virus resistance.
Juliarena MA; Poli M; Ceriani C; Sala L; Rodríguez E; Gutierrez S; Dolcini G; Odeon A; Esteban EN
J Dairy Sci; 2009 Jan; 92(1):375-81. PubMed ID: 19109295
[TBL] [Abstract][Full Text] [Related]
24. Expression of the bovine leukemia virus envelope glycoprotein (gp51) by recombinant baculovirus and its use in an enzyme-linked immunosorbent assay.
De Giuseppe A; Feliziani F; Rutili D; De Mia GM
Clin Diagn Lab Immunol; 2004 Jan; 11(1):147-51. PubMed ID: 14715562
[TBL] [Abstract][Full Text] [Related]
25. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep.
Kabeya H; Ohashi K; Ohishi K; Sugimoto C; Amanuma H; Onuma M
Vaccine; 1996 Aug; 14(12):1118-22. PubMed ID: 8911007
[TBL] [Abstract][Full Text] [Related]
26. BLV: lessons on vaccine development.
Abdala A; Alvarez I; Brossel H; Calvinho L; Carignano H; Franco L; Gazon H; Gillissen C; Hamaidia M; Hoyos C; Jacques JR; Joris T; Laval F; Petersen M; Porquet F; Porta N; Ruiz V; Safari R; Suárez Archilla G; Trono K; Willems L
Retrovirology; 2019 Oct; 16(1):26. PubMed ID: 31590667
[TBL] [Abstract][Full Text] [Related]
27. Bovine leukaemia virus and enzootic bovine leukosis.
Burny A; Bruck C; Cleuter Y; Couez D; Deschamps J; Gregoire D; Ghysdael J; Kettmann R; Mammerickx M; Marbaix G
Onderstepoort J Vet Res; 1985 Sep; 52(3):133-44. PubMed ID: 3003647
[TBL] [Abstract][Full Text] [Related]
28. Development and in vitro characterization of recombinant vaccinia viruses expressing bovine leukemia virus gp51 in combination with bovine IL4 or IL12.
Von Beust BR; Brown WC; Estes DM; Zarlenga DS; McElwain TF; Palmer GH
Vaccine; 1999 Jan; 17(4):384-95. PubMed ID: 9987178
[TBL] [Abstract][Full Text] [Related]
29. Protection against bovine leukemia virus infection by use of inactivated vaccines in cattle.
Fukuyama S; Kodama K; Hirahara T; Nakajima N; Takamura K; Sasaki O; Imanishi J
J Vet Med Sci; 1993 Feb; 55(1):99-106. PubMed ID: 8384897
[TBL] [Abstract][Full Text] [Related]
30. Progression to persistent lymphocytosis and tumor development in bovine leukemia virus (BLV)-infected cattle correlates with impaired proliferation of CD4+ T cells in response to gag- and env-encoded BLV proteins.
Orlik O; Splitter GA
J Virol; 1996 Nov; 70(11):7584-93. PubMed ID: 8892878
[TBL] [Abstract][Full Text] [Related]
31. Sequencing and phylogenetic analysis of gp51 gene of bovine leukaemia virus in Iranian isolates.
Hemmatzadeh F
Vet Res Commun; 2007 Aug; 31(6):783-9. PubMed ID: 17294262
[TBL] [Abstract][Full Text] [Related]
32. Absence of Bovine leukemia virus (BLV) infection in buffaloes from Amazon and southeast region in Brazil.
De Oliveira CH; Resende CF; Oliveira CM; Barbosa JD; Fonseca AA; Leite RC; Reis JK
Prev Vet Med; 2016 Jul; 129():9-12. PubMed ID: 27317318
[TBL] [Abstract][Full Text] [Related]
33. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development.
Gatei MH; Good MF; Daniel RC; Lavin MF
J Virol; 1993 Apr; 67(4):1796-802. PubMed ID: 7680386
[TBL] [Abstract][Full Text] [Related]
34. Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T cell-based vaccine.
Mateo L; Gardner J; Suhrbier A
AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1447-53. PubMed ID: 11679157
[TBL] [Abstract][Full Text] [Related]
35. Antigenicity of subregions of recombinant bovine leukemia virus (BLV) glycoprotein gp51 for antibody detection.
Bai L; Soya M; Ichikawa M; Matsuura R; Arimura Y; Wada S; Aida Y
J Virol Methods; 2023 Jan; 311():114644. PubMed ID: 36332713
[TBL] [Abstract][Full Text] [Related]
36. Protection against bovine leukosis virus infection in sheep with the BL 20 bovine lymphoblastoid cell line.
Roberts DH; Lucas MH; Sands J; Wibberley G
Vet Immunol Immunopathol; 1982 Nov; 3(6):635-42. PubMed ID: 6294966
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of a recombinant vaccinia virus expressing envelope a glycoprotein of bovine leukaemia virus.
Ohishi K; Maruyama T; Shida H; Nishimaki J; Miki K; Sagata N; Ikawa Y; Sugimoto M
Vaccine; 1988 Oct; 6(5):428-32. PubMed ID: 2848378
[TBL] [Abstract][Full Text] [Related]
38. The influence of ovine MHC class II DRB1 alleles on immune response in bovine leukemia virus infection.
Konnai S; Takeshima SN; Tajima S; Yin SA; Okada K; Onuma M; Aida Y
Microbiol Immunol; 2003; 47(3):223-32. PubMed ID: 12725293
[TBL] [Abstract][Full Text] [Related]
39. Long-term infection with retroviral structural gene vector provides protection against bovine leukemia virus disease in rabbits.
Altanerova V; Holicova D; Kucerova L; Altaner C; Lairmore MD; Boris-Lawrie K
Virology; 2004 Nov; 329(2):434-9. PubMed ID: 15518821
[TBL] [Abstract][Full Text] [Related]
40. Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model.
Kucerova L; Altanerova V; Altaner C; Boris-Lawrie K
J Virol; 1999 Oct; 73(10):8160-6. PubMed ID: 10482566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
